Skip to main content
. 2021 Sep 27;71(5):1093–1101. doi: 10.1007/s00262-021-03052-w

Fig. 3.

Fig. 3

Metastases sites. a Baseline metastases sites of patients before treatment. b Progression sites after treatment with atezolizumab, etoposide, and carboplatin